GRI GRI Bio, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
GRI
—
—
Key stats
Related
About
- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 5
- List Date
- 2023-04-24
- CIK
- 0001824293
- Next Earnings
- 2026-11-13
- EPS Forecast
- ($0.84) (2 est.)
- Headquarters
- La Jolla, CA
- Homepage
- https://www.gribio.com
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | -- | -34.81% | -25.65% | -58.42% | -39.63% |
| Feb | -- | -58.95% | -26.03% | -10.84% | -31.94% |
| Mar | -- | -7.32% | -58.12% | -9.84% | -25.09% |
| Apr | -19.04% | -42.86% | -9.90% | -6.44% | -19.56% |
| May | -18.26% | -28.79% | -30.77% | -5.50% | -20.83% |
| Jun | -26.72% | -48.90% | 0.78% | -14.49% | -22.33% |
| Jul | -19.17% | -59.72% | -6.57% | -21.59% | -26.76% |
| Aug | -63.77% | -26.43% | 5.30% | 33.33% | -12.89% |
| Sep | 23.02% | -28.59% | 47.14% | 1.05% | 10.65% |
| Oct | -26.06% | 162.25% | -15.42% | -23.47%* | 24.32% |
| Nov | -49.08% | -37.86% | 25.00% | -- | -20.65% |
| Dec | -49.61% | 26.90% | -87.47% | -- | -36.73% |
| Total | -96.69% | -97.74% | -97.22% | -79.57% | -92.81% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $1.65
SMA 50: $1.83
SMA 200: $2.33
Current: $1.50
EMA 12: $1.52
EMA 26: $1.65
MACD: -0.1274 | Signal: -0.0112
BEARISH
ADX (14): 18.53
RANGE
+DI: 23.77
−DI: 23.42
Momentum Oscillators
RSI (14): 40.64
NEUTRAL
Stoch %K: 16.15
Stoch %D: 14.20
Williams %R: -75.00
Volume & Volatility
BB Upper: $2.10
BB Lower: $1.20
NEUTRAL
OBV: 7,805,287
Vol SMA 20: 44,660
Vol ROC: -81.85%
ATR: $0.14
True Range: $0.08
HV 20: 69.8%
HV 30: 67.1%
HV 60: 136.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
Here is a comprehensive stock analysis report for GRI:
Executive Summary
BULLISH with confidence level 7/10
Key drivers: Positive news sentiment, moderate momentum signals, and a relatively high beta.
Primary risks: High volatility, negative news sentiment, and potential technical breakdowns.
Investment thesis: GRI has been experiencing positive momentum driven by recent news headlines and is likely to continue trending upward. However, caution should be exercised due to its high volatility and potential for significant price movements.
Recent news sentiment impact: The overall sentiment is positive, with four out of six recent news headlines having a positive tone. This suggests that the market is likely to respond favorably to further positive developments.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): Bullish trend
Support/Resistance Levels: Key price levels are $1.52 (lower Bollinger Band), $1.80 (EMA 12), and $2.29 (upper Bollinger Band).
Momentum Signals:
- RSI interpretation: Neutral (33.38)
- MACD signal: Bearish (MACD: -0.11 / Signal: -0.01 / Histogram: -0.10)
- Bollinger Bands position: Neutral (Price touching middle band)
Volume Analysis: Volume trends suggest institutional interest, with a volume rate of change of -65.40%.
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines have been predominantly positive, highlighting the company's patent approvals, executive appointments, and warrant exercises.
Sentiment Assessment: The overall sentiment is positive, with four out of six recent news headlines having a positive tone.
Catalyst Identification: No specific catalysts identified in the recent news headlines.
Market Narrative: The positive news sentiment aligns with the technical signals, suggesting that GRI may continue to trend upward.
Risk & Volatility Assessment
Beta Interpretation: Beta is 1.16 (vs SPY), indicating a relatively high level of volatility and risk.
Volatility Regime: Current volatility levels are above average.
Options Market Signals: No options data available.
Downside Protection: Support levels include $1.52 (lower Bollinger Band) and $1.80 (EMA 12).
Market Context & Positioning
Sector Performance: GRI is underperforming its sector peers.
Institutional Activity: Institutional interest is moderate, with a volume rate of change of -65.40%.
Correlation Analysis: The stock has a low correlation coefficient (0.11) with the SPY ETF, indicating that it moves independently of the market.
Relative Valuation: GRI appears to be trading within a trading range, with no clear relative value assessment.
Key Levels & Action Items
Critical Price Levels: Support levels include $1.52 and $1.80, while resistance levels are at $2.29 (upper Bollinger Band).
Breakout/Breakdown Levels: A breakout above $2.29 could signal a significant uptrend, while a breakdown below $1.52 could indicate a more substantial decline.
Time-Sensitive Catalysts: No specific catalysts identified in the recent news headlines.
Risk Management: Consider placing stop-loss orders at $1.50 and adjusting position size based on market volatility.
Note: The analysis above is based on the provided data and should not be taken as investment advice.
Generated
News
All GRI news →
GRI Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 0.9251
Alpha: -281.37%
Correlation: 0.0926
R-Squared: 0.9%
Stock Volatility: 127.3%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
Moderate volatility - stock generally follows market
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Notable investors who own GRI
1 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $24K | #6147 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
GRI Institutional Ownership (13F)
Latest filings — 2026-06-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
GRI Insider Trading (Form 4)
Latest: 2025-09-22Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2025-09-22 | Walter Marc Hertz | Chief Executive Officer | Grant (A) | +103,067 opt | — | EDGAR | |
| 2025-09-22 | David Charles Baker | Director | Grant (A) | +23,605 opt | — | EDGAR | |
| 2025-09-22 | David Leslie Szekeres | Director | Grant (A) | +39,897 opt | — | EDGAR | |
| 2025-09-22 | Leanne Kelly | Chief Financial Officer | Grant (A) | +43,222 opt | — | EDGAR | |
| 2025-09-22 | Roelof Rongen | Director | Grant (A) | +23,605 opt | — | EDGAR | |
| 2025-09-22 | Camilla V Simpson | Director | Grant (A) | +23,605 opt | — | EDGAR | |
| 2025-09-22 | Vipin Chaturvedi | Chief Scientific Officer | Grant (A) | +43,222 opt | — | EDGAR | |
| 2025-08-27 | Vipin Chaturvedi | Chief Scientific Officer | Grant (A) | +11,854 opt | — | EDGAR | |
| 2025-08-27 | David Charles Baker | Director | Grant (A) | +5,994 opt | — | EDGAR | |
| 2025-08-27 | Camilla V Simpson | Director | Grant (A) | +5,994 opt | — | EDGAR | |
| 2025-08-27 | Roelof Rongen | Director | Grant (A) | +5,994 opt | — | EDGAR | |
| 2025-08-27 | Leanne Kelly | Chief Financial Officer | Grant (A) | +11,854 opt | — | EDGAR | |
| 2025-08-27 | Walter Marc Hertz | Chief Executive Officer | Grant (A) | +26,688 opt | — | EDGAR | |
| 2025-08-27 | David Leslie Szekeres | Director | Grant (A) | +10,276 opt | — | EDGAR | |
| 2025-08-14 | David Charles Baker | Director | Grant (A) | +4,527 opt | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
GRI Board & Officers
As of SEC filings through Sep 22, 2025Directors 4
- Camilla V Simpson · since Apr 21, 2023
- David Leslie Szekeres · since Apr 21, 2023
- Roelof Rongen · since Apr 21, 2023
- Walter Marc Hertz · on file since Apr 2023
Officers 3
- Walter Marc Hertz · Chief Executive Officer · on file since Apr 2023
- Leanne Kelly · Chief Financial Officer · since May 11, 2021
- Vipin Chaturvedi · Chief Scientific Officer · on file since Apr 2023
Changes in the last 10 years (27)
| Jan 24, 2025 | Walter Marc Hertz no longer listed as a 10% owner in SEC filings |
| Aug 14, 2023 | David Charles Baker no longer listed as Chief Executive Officer in SEC filings |
| Apr 24, 2023 | Walter Marc Hertz first on file as a director |
| Apr 24, 2023 | Walter Marc Hertz first on file as a 10% owner |
| Apr 24, 2023 | Walter Marc Hertz first on file as Chief Executive Officer |
| Apr 24, 2023 | Vipin Chaturvedi first on file as Chief Scientific Officer |
| Apr 24, 2023 | Albert Agro first on file as Chief Medical Officer |
| Apr 21, 2023 | The company announced the departure of David Charles Baker from the board in an SEC filing |
| Apr 21, 2023 | Roelof Rongen became a director |
| Apr 21, 2023 | David Leslie Szekeres became a director |
| Apr 21, 2023 | Camilla V Simpson became a director |
| Mar 28, 2022 | The company announced the departure of Ofir Levi from the board in an SEC filing |
| Feb 23, 2022 | Meenu Chhabra became a director |
| May 18, 2021 | Joseph E Payne no longer listed as a 10% owner in SEC filings |
| May 11, 2021 | Leanne Kelly became Chief Financial Officer |
| Feb 12, 2021 | Richard Ammer no longer listed as a 10% owner in SEC filings |
| Feb 9, 2021 | SALMON Pharma GmbH became a 10% owner |
| Feb 9, 2021 | Richard Ammer became a director |
| Feb 9, 2021 | Richard Ammer became a 10% owner |
| Feb 9, 2021 | Penny Toren became SVP, Regul Affairs & Prog Mgmt |
| Feb 9, 2021 | Ofir Levi became a director |
| Feb 9, 2021 | Marella Thorell became a director |
| Feb 9, 2021 | Joseph E Payne became a director |
| Feb 9, 2021 | Joseph E Payne became a 10% owner |
| Feb 9, 2021 | David Charles Baker became a director |
| Feb 9, 2021 | David Charles Baker became Chief Executive Officer |
| Feb 9, 2021 | Arcturus Therapeutics Holdings Inc. became a 10% owner |
Not reported recently (8)
- Albert Agro · Last reported as Chief Medical Officer in an SEC filing dated Apr 25, 2023
- Marella Thorell · Last reported as a director in an SEC filing dated Dec 15, 2022
- Richard Ammer · Last reported as a director in an SEC filing dated Jun 10, 2022
- Joseph E Payne · Last reported as a director in an SEC filing dated Jun 10, 2022
- Meenu Chhabra · Last reported as a director in an SEC filing dated Mar 9, 2022
- Penny Toren · Last reported as SVP, Regul Affairs & Prog Mgmt in an SEC filing dated May 18, 2021
- SALMON Pharma GmbH · Last reported as a 10% owner in an SEC filing dated Feb 12, 2021
- Arcturus Therapeutics Holdings Inc. · Last reported as a 10% owner in an SEC filing dated Feb 10, 2021
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
24 ETFs hold GRI
24 shown · $88.20M total exposure · 0.01% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VXUS Vanguard Total International Stock ETF | Vanguard | 0.00% | $23.9M | — | 2026-09-30 |
| 2 | VEA Vanguard FTSE Developed Markets ETF | Vanguard | 0.01% | $15.8M | — | 2026-09-30 |
| 3 | IEFA iShares Core MSCI EAFE ETF | iShares (BlackRock) | 0.01% | $12.4M | $189.0B | 2026-10-23 |
| 4 | VSS Vanguard FTSE All-World EX-US Small-Cap Index Fund | Vanguard | 0.04% | $6.2M | — | 2026-09-30 |
| 5 | SCZ iShares MSCI EAFE Small-Cap ETF | iShares (BlackRock) | 0.04% | $5.7M | $12.8B | 2026-10-23 |
| 6 | VNQI Vanguard Global ex-U.S. Real Estate ETF | Vanguard | 0.15% | $5.3M | — | 2026-09-30 |
| 7 | REET iShares Global REIT ETF | iShares (BlackRock) | 0.10% | $4.9M | $4.8B | 2026-10-23 |
| 8 | VGK Vanguard FTSE Europe ETF | Vanguard | 0.01% | $3.9M | — | 2026-09-30 |
| 9 | IXUS iShares Core MSCI Total International Stock ETF | iShares (BlackRock) | 0.00% | $2.4M | $57.1B | 2026-10-23 |
| 10 | IDEV iShares Core MSCI International Developed Markets ETF | iShares (BlackRock) | 0.01% | $1.9M | $33.7B | 2026-10-23 |
| 11 | RWO State Street® SPDR® Dow Jones® Global Real Estate ETF | SPDR (State Street) | 0.10% | $1.2M | $1.2B | 2026-10-23 |
| 12 | VT Vanguard Total World Stock ETF | Vanguard | 0.00% | $1.1M | — | 2026-09-30 |
| 13 | IEUR iShares Core MSCI Europe ETF | iShares (BlackRock) | 0.01% | $1.1M | $9.4B | 2026-10-23 |
| 14 | RWX State Street® SPDR® Dow Jones® International Real Estate ETF | SPDR (State Street) | 0.37% | $856,168 | $232.2M | 2026-10-23 |
| 15 | GWX State Street® SPDR® S&P® International Small Cap ETF | SPDR (State Street) | 0.04% | $377,379 | $896.9M | 2026-10-23 |
| 16 | VSGX Vanguard ESG International Stock ETF | Vanguard | 0.01% | $357,957 | — | 2026-10-23 |
| 17 | IFGL iShares International Developed Real Estate ETF | iShares (BlackRock) | 0.27% | $209,368 | $77.8M | 2026-10-23 |
| 18 | IEUS iShares MSCI Europe Small-Cap ETF | iShares (BlackRock) | 0.11% | $172,905 | $164.5M | 2026-10-23 |
| 19 | EWUS iShares MSCI United Kingdom Small-Cap ETF | iShares (BlackRock) | 0.36% | $142,337 | $39.9M | 2026-10-23 |
| 20 | ISCF iShares International Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.02% | $127,754 | $699.5M | 2026-10-23 |
| 21 | WSML iShares MSCI World Small-Cap ETF | iShares (BlackRock) | 0.02% | $103,530 | $657.8M | 2026-10-23 |
| 22 | SPEU State Street® SPDR® Portfolio Europe ETF | SPDR (State Street) | 0.01% | $67,854 | $694.7M | 2026-10-23 |
| 23 | VXF Vanguard Extended Market ETF | Vanguard | 0.00% | $41,240 | — | 2026-09-30 |
| 24 | ERET iShares Environmentally Aware Real Estate ETF | iShares (BlackRock) | 0.10% | $13,320 | $13.3M | 2026-10-23 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.